Pediatrix Medical Group (MD) Competitors $13.13 -0.37 (-2.72%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$13.12 -0.01 (-0.06%) As of 07/11/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MD vs. AMED, AMN, CCRN, LH, DGX, DVA, CHE, CRVL, BTSG, and SHCShould you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Labcorp (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), CorVel (CRVL), BrightSpring Health Services (BTSG), and Sotera Health (SHC). Pediatrix Medical Group vs. Its Competitors Amedisys AMN Healthcare Services Cross Country Healthcare Labcorp Quest Diagnostics DaVita Chemed CorVel BrightSpring Health Services Sotera Health Pediatrix Medical Group (NYSE:MD) and Amedisys (NASDAQ:AMED) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations, risk and media sentiment. Do institutionals & insiders believe in MD or AMED? 97.7% of Pediatrix Medical Group shares are owned by institutional investors. Comparatively, 94.4% of Amedisys shares are owned by institutional investors. 0.9% of Pediatrix Medical Group shares are owned by company insiders. Comparatively, 2.1% of Amedisys shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has preferable earnings & valuation, MD or AMED? Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPediatrix Medical Group$2.01B0.56-$99.07M-$1.01-13.00Amedisys$2.35B1.36$43.23M$2.7135.86 Does the media refer more to MD or AMED? In the previous week, Pediatrix Medical Group had 1 more articles in the media than Amedisys. MarketBeat recorded 2 mentions for Pediatrix Medical Group and 1 mentions for Amedisys. Pediatrix Medical Group's average media sentiment score of 1.63 beat Amedisys' score of -0.01 indicating that Pediatrix Medical Group is being referred to more favorably in the media. Company Overall Sentiment Pediatrix Medical Group Very Positive Amedisys Neutral Which has more risk & volatility, MD or AMED? Pediatrix Medical Group has a beta of 1.25, suggesting that its share price is 25% more volatile than the S&P 500. Comparatively, Amedisys has a beta of 0.94, suggesting that its share price is 6% less volatile than the S&P 500. Do analysts rate MD or AMED? Pediatrix Medical Group presently has a consensus price target of $16.67, indicating a potential upside of 26.91%. Amedisys has a consensus price target of $100.75, indicating a potential upside of 3.67%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Pediatrix Medical Group is more favorable than Amedisys.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pediatrix Medical Group 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33Amedisys 0 Sell rating(s) 3 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.25 Is MD or AMED more profitable? Amedisys has a net margin of 3.79% compared to Pediatrix Medical Group's net margin of -4.17%. Pediatrix Medical Group's return on equity of 17.43% beat Amedisys' return on equity.Company Net Margins Return on Equity Return on Assets Pediatrix Medical Group-4.17% 17.43% 6.35% Amedisys 3.79%12.52%7.01% SummaryPediatrix Medical Group and Amedisys tied by winning 8 of the 16 factors compared between the two stocks. Get Pediatrix Medical Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MD vs. The Competition Export to ExcelMetricPediatrix Medical GroupMedical Services IndustryMedical SectorNYSE ExchangeMarket Cap$1.13B$7.32B$5.56B$20.62BDividend YieldN/A2.84%5.06%3.72%P/E Ratio-13.0034.5428.2627.81Price / Sales0.5635.93408.4840.78Price / Cash7.4423.1337.1222.32Price / Book1.476.858.044.57Net Income-$99.07M$236.02M$3.19B$989.30M7 Day Performance-4.70%0.01%3.62%0.20%1 Month Performance-6.33%2.76%5.98%5.53%1 Year Performance77.47%33.80%29.39%10.30% Pediatrix Medical Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDPediatrix Medical Group2.8295 of 5 stars$13.13-2.7%$16.67+26.9%+77.5%$1.13B$2.01B-13.004,305AMEDAmedisys2.5465 of 5 stars$96.50+0.4%$100.75+4.4%-0.9%$3.15B$2.35B35.6119,000AMNAMN Healthcare Services4.2399 of 5 stars$21.23-3.1%$32.08+51.1%-57.5%$839.20M$2.98B-4.902,968News CoverageCCRNCross Country Healthcare4.0266 of 5 stars$12.75-2.0%$17.93+40.6%-12.5%$426.51M$1.34B-24.068,205Positive NewsLHLabcorp4.7133 of 5 stars$257.78-1.6%$276.08+7.1%+20.9%$21.92B$13.01B29.8070,000Trending NewsDividend AnnouncementAnalyst ForecastAnalyst RevisionDGXQuest Diagnostics4.9715 of 5 stars$173.78-1.8%$185.73+6.9%+16.6%$19.75B$9.87B21.9756,000News CoveragePositive NewsAnalyst RevisionDVADaVita4.4566 of 5 stars$142.71+0.1%$164.50+15.3%+0.6%$10.76B$12.82B14.1476,000News CoveragePositive NewsCHEChemed4.985 of 5 stars$461.20-2.5%$645.00+39.9%-14.5%$6.92B$2.43B22.4615,695CRVLCorVel1.0168 of 5 stars$100.00-2.8%N/A+10.0%$5.29B$895.59M54.455,075News CoveragePositive NewsBTSGBrightSpring Health Services1.7457 of 5 stars$22.00-0.5%$24.90+13.2%+83.6%$3.89B$11.27B78.5735,000SHCSotera Health3.1545 of 5 stars$11.40-2.9%$16.00+40.4%-4.5%$3.33B$1.10B18.943,000 Related Companies and Tools Related Companies AMED Competitors AMN Competitors CCRN Competitors LH Competitors DGX Competitors DVA Competitors CHE Competitors CRVL Competitors BTSG Competitors SHC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:MD) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pediatrix Medical Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pediatrix Medical Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
